Lista de obras -

Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile.

artículo científico publicado en 2013

Alcohol septal ablation in patients with severe septal hypertrophy

scientific article published on 30 August 2019

Cardiomyopathy in Friedreich ataxia: exemplifying the challenges faced by cardiologists in the management of rare diseases

artículo científico publicado en 2012

Comparison of Valsalva manoeuvre and exercise in echocardiographic evaluation of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy

artículo científico publicado en 2010

Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives

artículo científico publicado en 2009

Echocardiographic evaluation of pre-diagnostic development in young relatives genetically predisposed to hypertrophic cardiomyopathy.

artículo científico publicado en 2015

Effect of Institutional Experience on Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

artículo científico publicado en 2018

Effect of impaired cardiac conduction after alcohol septal ablation on clinical outcomes: Insights from the Euro-ASA registry

article

Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2014

Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women

artículo científico publicado en 2010

Functional effects of losartan in hypertrophic cardiomyopathy-a randomised clinical trial.

artículo científico publicado en 2015

Hypertrophic Cardiomyopathy in Childhood: Risk Management Through Family Screening

artículo científico publicado en 2017

Left ventricular volume predicts exercise capacity in hypertrophic cardiomyopathy

artículo científico publicado en 2015

Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry.

artículo científico publicado en 2016

Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry

scientific article published on 10 August 2020

Long-term survival and causes of death in patients with ST-elevation acute coronary syndrome without obstructive coronary artery disease.

artículo científico publicado en 2017

Low procedure-related mortality achieved with alcohol septal ablation in European patients.

artículo científico publicado en 2016

MT-CYB mutations in hypertrophic cardiomyopathy.

artículo científico publicado en 2013

Mitochondrial haplogroups modify the risk of developing hypertrophic cardiomyopathy in a Danish population.

artículo científico publicado en 2013

New and existing risk factors in patients with hypertrophic cardiomyopathy

artículo científico publicado en 2015

Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry

artículo científico publicado en 2017

Outcomes of Alcohol Septal Ablation in Younger Patients With Obstructive Hypertrophic Cardiomyopathy.

artículo científico publicado en 2017

Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing

artículo científico publicado en 2012

Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy

scientific article published on 08 January 2019

Private mitochondrial DNA variants in danish patients with hypertrophic cardiomyopathy.

artículo científico publicado en 2015

Risk of Cardiomyopathy in Younger Persons With a Family History of Death from Cardiomyopathy: A Nationwide Family Study in a Cohort of 3.9 Million Persons.

artículo científico publicado en 2015

Short- and long-term outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with mild left ventricular hypertrophy: a propensity score matching analysis

artículo científico publicado en 2019

Survival and sudden cardiac death after septal ablation for hypertrophic obstructive cardiomyopathy.

artículo científico publicado en 2011

The KCNE genes in hypertrophic cardiomyopathy: a candidate gene study.

artículo científico publicado en 2011

Validation of the HCM Risk-SCD model in patients with hypertrophic cardiomyopathy following alcohol septal ablation.

artículo científico publicado en 2017

Lista de obras de

Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile.

Alcohol septal ablation in patients with severe septal hypertrophy

Cardiomyopathy in Friedreich ataxia: exemplifying the challenges faced by cardiologists in the management of rare diseases

Comparison of Valsalva manoeuvre and exercise in echocardiographic evaluation of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy

Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives

Echocardiographic evaluation of pre-diagnostic development in young relatives genetically predisposed to hypertrophic cardiomyopathy.

Effect of Institutional Experience on Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Effect of impaired cardiac conduction after alcohol septal ablation on clinical outcomes: Insights from the Euro-ASA registry

Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial

Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women

Functional effects of losartan in hypertrophic cardiomyopathy-a randomised clinical trial.

Hypertrophic Cardiomyopathy in Childhood: Risk Management Through Family Screening

Left ventricular volume predicts exercise capacity in hypertrophic cardiomyopathy

Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry.

Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry

Long-term survival and causes of death in patients with ST-elevation acute coronary syndrome without obstructive coronary artery disease.

Low procedure-related mortality achieved with alcohol septal ablation in European patients.

MT-CYB mutations in hypertrophic cardiomyopathy.

Mitochondrial haplogroups modify the risk of developing hypertrophic cardiomyopathy in a Danish population.

New and existing risk factors in patients with hypertrophic cardiomyopathy

Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry

Outcomes of Alcohol Septal Ablation in Younger Patients With Obstructive Hypertrophic Cardiomyopathy.

Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing

Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy

Private mitochondrial DNA variants in danish patients with hypertrophic cardiomyopathy.

Risk of Cardiomyopathy in Younger Persons With a Family History of Death from Cardiomyopathy: A Nationwide Family Study in a Cohort of 3.9 Million Persons.

Short- and long-term outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with mild left ventricular hypertrophy: a propensity score matching analysis

Survival and sudden cardiac death after septal ablation for hypertrophic obstructive cardiomyopathy.

The KCNE genes in hypertrophic cardiomyopathy: a candidate gene study.

Validation of the HCM Risk-SCD model in patients with hypertrophic cardiomyopathy following alcohol septal ablation.